Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1999
03/25/1999WO1999013909A1 Corneal neovascularization inhibitors
03/25/1999WO1999013908A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999WO1999013907A2 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999WO1999013903A1 Methods and compositions for diagnosing and treating malaria
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
03/25/1999WO1998054225A3 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
03/25/1999WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions
03/25/1999WO1998048001A9 Methods for differentiating neural stem cells
03/25/1999DE19741715A1 New pentopyranosyl nucleoside compounds
03/25/1999CA2382506A1 Novel polypeptides and nucleic acids encoding pro293 which are useful for treating disorders of the pancreas
03/25/1999CA2382495A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382409A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304368A1 Reagents and methods useful for detecting diseases of the prostate, breast and ovary
03/25/1999CA2304309A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999CA2304208A1 Intrabody-mediated control of immune reactions
03/25/1999CA2304170A1 P53-induced apoptosis
03/25/1999CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999CA2304124A1 Bci-2-like protein bim and methods of use thereof
03/25/1999CA2304011A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303775A1 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999CA2303759A1 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2296045A1 Persephin and related growth factors
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/25/1999CA2244954A1 Murf
03/24/1999WO1999015691A1 Method for diagnosing bone dysbolism
03/24/1999EP0903409A2 Aminopeptidase (AmpS)
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902837A1 Tailless nuclear hormone receptor (tlx receptor)
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes
03/24/1999EP0739413B1 Method of selecting specific bacteriophages
03/24/1999EP0738282B1 Novel chimeric antibodies, their use and process for producing them
03/24/1999EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof
03/24/1999EP0556320B1 Monoclonal antibodies to hepatitis c virus and method for using the same
03/24/1999EP0534978B1 Interleukin-1 antagonist and uses thereof
03/24/1999CN1212017A Hybrid proteins which form heterodimers
03/24/1999CN1211924A Immunomodulatory complex for helicobacter bacteria
03/24/1999CN1211918A TNF－α转变酶 TNF-α converting enzyme
03/24/1999CN1211449A Neospora veccine
03/24/1999CA2269114A1 Method for diagnosis of metabolic bone diseases
03/23/1999US5886154 Chromatographic method for high yield purification and viral inactivation of antibodies
03/23/1999US5886153 Antibodies directed against the alpha interferon receptor
03/23/1999US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering
03/23/1999US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
03/23/1999US5885830 Anti-ribonucleotide reductase R2 subunit monoclonal antibody
03/23/1999US5885827 Eukaryotic high rate mutagenesis system
03/23/1999US5885823 Bacteria strain atcc no.55783 are incubated in an oxygen concentration of from about 0 percent to about 18 percent, agitating the bacteria in suspension; veterinary medicine
03/23/1999US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting
03/23/1999US5885805 gbpA
03/23/1999US5885796 CTLA4 receptor and uses thereof
03/23/1999US5885793 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885589 Pasteurella vaccine
03/23/1999US5885579 CTLA4 receptor and uses thereof
03/23/1999US5885576 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/23/1999US5885575 Diagnosis and therapy of tumour metastases
03/23/1999US5885574 Antibodies which activate an erythropoietin receptor
03/23/1999US5885573 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885568 Coccidiosis poultry vaccine
03/23/1999CA2127462C Treatment for asthma
03/23/1999CA2052713C Delivery of agents
03/23/1999CA1340460C Electrochemiluminescent rhenium moieties and methods for their use
03/23/1999CA1340459C Method to produce immunodiagnostic reagents
03/23/1999CA1340456C Chimeric rodent/human immunoglobulins specific for tumor-associated antigens
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013111A1 Reagents and methods useful for detecting diseases of the prostate
03/18/1999WO1999013083A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth
03/18/1999WO1999013080A1 Beta-defensins
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013061A1 Plus end-directed microtubule motor required for chromosome congression
03/18/1999WO1999013060A1 Novel thermophilic polymerase iii holoenzyme
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012973A1 Monoclonal antibody inducing apoptosis
03/18/1999WO1999012972A1 Monoclonal antibody against human monocytes
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012959A1 Carbohydrate crosslinked glycoprotein crystals
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012553A1 Methods for producing human antibodies in scid mice using dendritic cells
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999WO1998057992A3 Anti-flip protein antibodies
03/18/1999WO1998057987A3 Irs-p53h, human insulin receptor tyrosine kinase substrate
03/18/1999WO1998057983A3 Mammalian neuro-growth factor like protein
03/18/1999WO1998057982A3 Aib1, a steroid receptor co-activator
1 ... 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 ... 1494